Form 4: AbbVie Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
EVP and Chief Commercial Officer of AbbVie, Jeffrey Ryan Stewart, sold shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units.
Summary
- On February 28, 2025, Jeffrey Ryan Stewart, EVP and Chief Commercial Officer of AbbVie Inc., engaged in a transaction involving AbbVie's common stock.
- Stewart sold 20,226 shares of common stock at a price of $205.02 per share to cover tax obligations.
- Following the transaction, Stewart directly owns 86,366 shares of AbbVie common stock.
- Stewart also indirectly owns 1,338 shares through a spouse's trust.
Sentiment
Score: 5
Explanation: Neutral sentiment. The filing simply reports a routine stock sale for tax purposes, with no indication of positive or negative implications for the company's performance.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook on the company's future, but it's a transaction investors monitor for potential insights.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of the stock sale transaction. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Keywords
AbbVie, ABBV, Jeffrey Ryan Stewart, Executive Compensation, Stock Sale, Form 4, Tax Obligations, EVP, Chief Commercial Officer, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.